Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
暂无分享,去创建一个
Deepak L. Bhatt | S. Yusuf | J. Bosch | G. Dagenais | S. Connolly | V. Aboyans | J. Eikelboom | J. Probstfield | K. Fox | B. Winkelmann | D. Leong | P. Widimsky | S. Berkowitz | L. Dyal | E. Muehlhofer